How many insider trades does FilingIQ track for APLM?

FilingIQ tracks 3 Form 4 insider transactions for APLM (Apollomics Inc.), covering filings from Mar 31, 2026 onwards. 3 of those were filed in the last 90 days.

Are APLM insiders net buyers or net sellers?

Across the full Form 4 history for APLM, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does APLM insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is APLM in?

Apollomics Inc. (APLM) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $29.84M.

APLM insider trading

NasdaqCM Healthcare

Apollomics Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

0% / 0%

Market cap

$29.84M

About Apollomics Inc.

Apollomics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. The company's products portfolio includes Vebreltinib (APL-101), an oral active, highly selective c-Met inhibitor, which is in Phase 2 clinical trials for treatment of non-small cell lung cancer and other solid tumors with MET dysregulation; APL-102, an oral active, small molecule multiple tyrosine kinase inhibitor, which is in a in a Phase 1 clinical trial to inhibit various kinases that are aberrantly activated in cancer cells; and APL-122, a tumor inhibitor candidate, targeting ErbB1/2/4 signaling pathways that is in Phase 1 dose escalation clinical trials to treat cancers within the brain. Its immuno-oncology product candidates comprise APL-501, APL-502, and APL-801. The company was founded in 2015 and is based in Foster City, California.

Company website: www.apollomicsinc.com

APLM insider activity at a glance

FilingIQ has scored 3 insider transactions for APLM since Mar 31, 2026. The most recent filing in our index is dated May 17, 2026.

Across the full history, 0 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

View live APLM trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,147

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 185

Adaptive Biotechnologies Corp

GH 173

Guardant Health, Inc.

ISRG 169

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for APLM?: FilingIQ tracks 3 Form 4 insider transactions for APLM (Apollomics Inc.), covering filings from Mar 31, 2026 onwards. 3 of those were filed in the last 90 days.
Are APLM insiders net buyers or net sellers?: Across the full Form 4 history for APLM, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does APLM insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is APLM in?: Apollomics Inc. (APLM) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $29.84M.

Methodology & sources

Every APLM insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.